Using NanoString GeoMX, we found TIMP1 expression in the immune compartment of the TME, which corresponded to higher immunogenicity in lymph nodes (LN) due to its association with MHC-I peptide loading, indicating TIMP-1’s possible impact on melanoma immunogenicity through DC priming. The gene discussed is TIMP1; the disease is melanoma.